{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:40:48Z","timestamp":1760168448380,"version":"build-2065373602"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,11]]},"DOI":"10.7759\/cureus.94323","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:19:16Z","timestamp":1760167156000},"source":"Crossref","is-referenced-by-count":0,"title":["Baseline Patient-Reported Health Status Predicts Hospitalization Duration and Cost in Chronic Heart Failure"],"prefix":"10.7759","author":[{"given":"Alexandra","family":"Minca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragos","family":"Minc\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Calinoiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adina","family":"Rusu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ciobanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriu","family":"Gheorghita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana G","family":"Minc\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14687","article-title":"Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement","volume":"11","author":"Chioncel O","year":"2024","unstructured":"Chioncel O, \u010celutkien\u0117 J, B\u011blohl\u00e1vek J, et al.. Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement. ESC Heart Fail. 2024, 11:1861-74. 10.1002\/ehf2.14687","journal-title":"ESC Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.03.033","article-title":"The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry","volume":"162","author":"Chioncel O","year":"2011","unstructured":"Chioncel O, Vinereanu D, Datcu M, et al.. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J. 2011, 162:142-53. 10.1016\/j.ahj.2011.03.033","journal-title":"Am Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2024.01.010","article-title":"The economics of heart failure care","volume":"82","author":"Wei C","year":"2024","unstructured":"Wei C, Heidenreich PA, Sandhu AT. The economics of heart failure care. Prog Cardiovasc Dis. 2024, 82:90-101. 10.1016\/j.pcad.2024.01.010","journal-title":"Prog Cardiovasc Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad583","article-title":"Economic burden of cardiovascular diseases in the European Union: a population-based cost study","volume":"44","author":"Luengo-Fernandez R","year":"2023","unstructured":"Luengo-Fernandez R, Walli-Attaei M, Gray A, et al.. Economic burden of cardiovascular diseases in the European Union: a population-based cost study. Eur Heart J. 2023, 44:4752-67. 10.1093\/eurheartj\/ehad583","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.011584","article-title":"Challenges related to out-of-pocket costs in heart failure management","volume":"18","author":"Rao BR","year":"2025","unstructured":"Rao BR, Allen LA, Sandhu AT, Dickert NW. Challenges related to out-of-pocket costs in heart failure management. Circ Heart Fail. 2025, 18:e011584. 10.1161\/CIRCHEARTFAILURE.124.011584","journal-title":"Circ Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.072158","article-title":"Patient-reported outcomes as end points in heart failure trials","volume":"151","author":"Butler J","year":"2025","unstructured":"Butler J, Usman MS, Gandotra C, et al.. Patient-reported outcomes as end points in heart failure trials. Circulation. 2025, 151:1111-25. 10.1161\/CIRCULATIONAHA.124.072158","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.10.019","article-title":"Patient-reported outcomes in heart failure: delivering more dimensions","volume":"13","author":"Fonarow GC","year":"2025","unstructured":"Fonarow GC, Tang AB. Patient-reported outcomes in heart failure: delivering more dimensions. JACC Heart Fail. 2025, 13:293-5. 10.1016\/j.jchf.2024.10.019","journal-title":"JACC Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.124.011423","article-title":"Patient-reported outcomes in heart failure clinical trials: trends, utilization, and implications","volume":"18","author":"Liu X","year":"2025","unstructured":"Liu X, Lan RH, Sandhu AT. Patient-reported outcomes in heart failure clinical trials: trends, utilization, and implications. Circ Cardiovasc Qual Outcomes. 2025, 18:e011423. 10.1161\/CIRCOUTCOMES.124.011423","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.115.001958","article-title":"Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire","volume":"8","author":"Spertus JA","year":"2015","unstructured":"Spertus JA, Jones PG. Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes. 2015, 8:469-76. 10.1161\/CIRCOUTCOMES.115.001958","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review","volume":"76","author":"Spertus JA","year":"2020","unstructured":"Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 76:2379-90. 10.1016\/j.jacc.2020.09.542","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2196\/publichealth.4360","article-title":"Patient-reported outcomes and total health care expenditure in prediction of patient satisfaction: results from a national study","volume":"1","author":"Hung M","year":"2015","unstructured":"Hung M, Zhang W, Chen W, et al.. Patient-reported outcomes and total health care expenditure in prediction of patient satisfaction: results from a national study. JMIR Public Health Surveill. 2015, 1:e13. 10.2196\/publichealth.4360","journal-title":"JMIR Public Health Surveill"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2196\/51841","article-title":"Effectiveness of telemonitoring in reducing hospitalization and associated costs for patients with heart failure in Finland: nonrandomized pre-post telemonitoring study","volume":"12","author":"Kokkonen J","year":"2024","unstructured":"Kokkonen J, Mustonen P, Heikkil\u00e4 E, et al.. Effectiveness of telemonitoring in reducing hospitalization and associated costs for patients with heart failure in Finland: nonrandomized pre-post telemonitoring study. JMIR Mhealth Uhealth. 2024, 12:e51841. 10.2196\/51841","journal-title":"JMIR Mhealth Uhealth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08041-9","article-title":"A cluster-randomized study to evaluate the effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in South Tyrolean primary care for patients with COPD, asthma, type 2 diabetes, and heart failure: the ABCC South Tyrol study","volume":"25","author":"Wiedermann CJ","year":"2024","unstructured":"Wiedermann CJ, Marino P, Mahlknecht A, Barbieri V, Piccoliori G, Engl A, Gidding-Slok AH. A cluster-randomized study to evaluate the effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in South Tyrolean primary care for patients with COPD, asthma, type 2 diabetes, and heart failure: the ABCC South Tyrol study. Trials. 2024, 25:202. 10.1186\/s13063-024-08041-9","journal-title":"Trials"},{"key":"ref14","article-title":"Nomenclature and Criteria for Diagnosis for Diseases of the Heart and Great Vessels","author":"The Criteria Committee of the New York Heart Association","year":"1994","unstructured":"The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis for Diseases of the Heart and Great Vessels. Little Brown &amp; Co, Boston, MA; 1994."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson ME","year":"1987","unstructured":"Charlson ME, Pompei P. Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40:373-83. 10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcab014","article-title":"Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure","volume":"7","author":"Thomas M","year":"2021","unstructured":"Thomas M, Jones PG, Cohen DJ, et al.. Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure. Eur Heart J Qual Care Clin Outcomes. 2021, 7:388-96. 10.1093\/ehjqcco\/qcab014","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.11.037","article-title":"Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living with Heart Failure Questionnaire in predicting heart failure outcomes","volume":"123","author":"Yee D","year":"2019","unstructured":"Yee D, Novak E, Platts A, Nassif ME, LaRue SJ, Vader JM. Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living with Heart Failure Questionnaire in predicting heart failure outcomes. Am J Cardiol. 2019, 123:807-12. 10.1016\/j.amjcard.2018.11.037","journal-title":"Am J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.02.006","article-title":"Comparing measures to assess health-related quality of life in heart failure with preserved ejection fraction","volume":"6","author":"Napier R","year":"2018","unstructured":"Napier R, McNulty SE, Eton DT, Redfield MM, AbouEzzeddine O, Dunlay SM. Comparing measures to assess health-related quality of life in heart failure with preserved ejection fraction. JACC Heart Fail. 2018, 6:552-60. 10.1016\/j.jchf.2018.02.006","journal-title":"JACC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang RM","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al.. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015, 28:1-39. 10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society, and Writing Committee of the Universal Definition of Heart Failure","volume":"27","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Coats AJ, Tsutsui H, et al.. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society, and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021, 27:387-413. 10.1016\/j.cardfail.2021.01.022","journal-title":"J Card Fail"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey AS","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150:604-12. 10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-015-0045-7","article-title":"Statistical models for the analysis of skewed healthcare cost data: a simulation study","volume":"5","author":"Malehi AS","year":"2015","unstructured":"Malehi AS, Pourmotahari F, Angali KA. Statistical models for the analysis of skewed healthcare cost data: a simulation study. Health Econ Rev. 2015, 5:11. 10.1186\/s13561-015-0045-7","journal-title":"Health Econ Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S395242","article-title":"Patient perspectives on the burden of heart failure with preserved ejection fraction in a US commercially insured and Medicare Advantage population: a survey study","volume":"17","author":"Nguyen C","year":"2023","unstructured":"Nguyen C, Bamber L, Willey VJ, Evers T, Power TP, Stephenson JJ. Patient perspectives on the burden of heart failure with preserved ejection fraction in a US commercially insured and Medicare Advantage population: a survey study. Patient Prefer Adherence. 2023, 17:1181-96. 10.2147\/PPA.S395242","journal-title":"Patient Prefer Adherence"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.820472","article-title":"Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)","volume":"119","author":"Chan PS","year":"2009","unstructured":"Chan PS, Soto G, Jones PG, Nallamothu BK, Zhang Z, Weintraub WS, Spertus JA. Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation. 2009, 119:398-407. 10.1161\/CIRCULATIONAHA.108.820472","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4571201","article-title":"Kansas City Cardiomyopathy Questionnaire utility in prediction of 30-day readmission rate in patients with chronic heart failure","volume":"2016","author":"Dai S","year":"2016","unstructured":"Dai S, Manoucheri M, Gui J, et al.. Kansas City Cardiomyopathy Questionnaire utility in prediction of 30-day readmission rate in patients with chronic heart failure. Cardiol Res Pract. 2016, 2016:1. 10.1155\/2016\/4571201","journal-title":"Cardiol Res Pract"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2013.11.010","article-title":"Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire","volume":"20","author":"Sauser K","year":"2014","unstructured":"Sauser K, Spertus JA, Pierchala L, Davis E, Pang PS. Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire. J Card Fail. 2014, 20:18-22. 10.1016\/j.cardfail.2013.11.010","journal-title":"J Card Fail"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2023.11.021","article-title":"Early discharge to clinic-based therapy of patients presenting with decompensated heart failure (EDICT-HF): study protocol for a multi-centre randomised controlled trial","volume":"33","author":"Ranasinghe MP","year":"2024","unstructured":"Ranasinghe MP, Koh Y, Vogrin S, et al.. Early discharge to clinic-based therapy of patients presenting with decompensated heart failure (EDICT-HF): study protocol for a multi-centre randomised controlled trial. Heart Lung Circ. 2024, 33:78-85. 10.1016\/j.hlc.2023.11.021","journal-title":"Heart Lung Circ"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01903-1","article-title":"Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)","volume":"111","author":"Becher MU","year":"2022","unstructured":"Becher MU, Balata M, Hesse M, et al.. Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF). Clin Res Cardiol. 2022, 111:359-67. 10.1007\/s00392-021-01903-1","journal-title":"Clin Res Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01604-9","article-title":"Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire","volume":"18","author":"Capota R","year":"2020","unstructured":"Capota R, Militaru S, Ionescu AA, Rosca M, Baicus C, Popescu BA, Jurcut R. Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire. Health Qual Life Outcomes. 2020, 18:351. 10.1186\/s12955-020-01604-9","journal-title":"Health Qual Life Outcomes"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/life14121564","article-title":"The relationship between the Kansas City Cardiomyopathy Questionnaire and electrocardiographic parameters in predicting outcomes after cardiac resynchronization therapy","volume":"14","author":"Rosu AM","year":"2024","unstructured":"Rosu AM, Tomescu LF, Badea TG, et al.. The relationship between the Kansas City Cardiomyopathy Questionnaire and electrocardiographic parameters in predicting outcomes after cardiac resynchronization therapy. Life (Basel). 2024, 14:4. 10.3390\/life14121564","journal-title":"Life (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417536-baseline-patient-reported-health-status-predicts-hospitalization-duration-and-cost-in-chronic-heart-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:19:17Z","timestamp":1760167157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417536-baseline-patient-reported-health-status-predicts-hospitalization-duration-and-cost-in-chronic-heart-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.94323","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,11]]}}}